Please assess the completion status of the following clinical trial:

Trial Title: 24-hour IOP-lowering Effect of 0.01% Bimatoprost

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* primary open-angle glaucoma or ocular hypertension~Exclusion Criteria:~* Women of childbearing potential previous glaucoma surgery presence of other eye disease

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- 0.01% bimatoprost (Type: EXPERIMENTAL): bimatoprost 0.01% one time per day at bedtime for 4 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).